{
  "nodes": [
    {
      "id": "node_001",
      "content": "CLINICAL ASSESSMENT\nStage IB (peripheral T2a, N0)\nStage I (central T1abc\u2013T2a, N0)\nStage II (T1abc\u2013T2ab, N1; T2b, N0)\nStage IIB (T3, N0)f\nStage IIIA (T3, N1)f",
      "parent_ids": [],
      "children_ids": [
        "node_002"
      ],
      "tree_ids": []
    },
    {
      "id": "node_002",
      "content": "PRETREATMENT EVALUATIONg\n\u2022 Molecular testing for EGFR, ALK; PD-L1 testing\n\u2022 Evaluate for perioperative therapyq\n\u2022 PFTs (if not previously done)\n\u2022 Bronchoscopy\n\u2022 Pathologic mediastinal lymph node evaluationh\n\u2022 FDG-PET/CT scank (if not previously done)\n\u2022 Brain MRI with contrastr (stage II, IIIA)\n(stage IB [optional])",
      "parent_ids": [
        "node_001"
      ],
      "children_ids": [
        "node_003",
        "node_014"
      ],
      "tree_ids": [
        "NSCL-E"
      ]
    },
    {
      "id": "node_003",
      "content": "N0 or N1",
      "parent_ids": [
        "node_002"
      ],
      "children_ids": [
        "node_004",
        "node_007"
      ],
      "tree_ids": []
    },
    {
      "id": "node_004",
      "content": "Operable",
      "parent_ids": [
        "node_003"
      ],
      "children_ids": [
        "node_005"
      ],
      "tree_ids": []
    },
    {
      "id": "node_005",
      "content": "Surgical exploration and resectionm + mediastinal lymph node dissection or systematic lymph node sampling after preoperative systemic therapy, if plannedp",
      "parent_ids": [
        "node_004"
      ],
      "children_ids": [
        "node_006"
      ],
      "tree_ids": [
        "NSCL-B"
      ]
    },
    {
      "id": "node_006",
      "content": "Findings at Surgery (NSCL-4)",
      "parent_ids": [
        "node_005"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-4"
      ]
    },
    {
      "id": "node_007",
      "content": "Medically inoperable, high surgical risk as determined by thoracic surgeon,m and those who decline surgery after thoracic surgical consultation",
      "parent_ids": [
        "node_003"
      ],
      "children_ids": [
        "node_008",
        "node_012"
      ],
      "tree_ids": [
        "NSCL-B"
      ]
    },
    {
      "id": "node_008",
      "content": "N0",
      "parent_ids": [
        "node_007"
      ],
      "children_ids": [
        "node_009"
      ],
      "tree_ids": []
    },
    {
      "id": "node_009",
      "content": "Definitive RT, preferably SABRh,p",
      "parent_ids": [
        "node_008"
      ],
      "children_ids": [
        "node_010"
      ],
      "tree_ids": [
        "NSCL-C"
      ]
    },
    {
      "id": "node_010",
      "content": "Consider adjuvant chemotherapyn for high-risk stage II (especially T2b\u20133)",
      "parent_ids": [
        "node_009"
      ],
      "children_ids": [
        "node_011"
      ],
      "tree_ids": [
        "NSCL-C"
      ]
    },
    {
      "id": "node_011",
      "content": "Surveillance (NSCL-17)",
      "parent_ids": [
        "node_010"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-17"
      ]
    },
    {
      "id": "node_012",
      "content": "N1",
      "parent_ids": [
        "node_007"
      ],
      "children_ids": [
        "node_013"
      ],
      "tree_ids": []
    },
    {
      "id": "node_013",
      "content": "NSCL-10",
      "parent_ids": [
        "node_012"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-10"
      ]
    },
    {
      "id": "node_014",
      "content": "N2 or N3",
      "parent_ids": [
        "node_002"
      ],
      "children_ids": [
        "node_015"
      ],
      "tree_ids": []
    },
    {
      "id": "node_015",
      "content": "Stage IIIA/IIIB (NSCL-8) or Stage IIIB/IIIC (NSCL-13)",
      "parent_ids": [
        "node_014"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-8",
        "NSCL-13"
      ]
    }
  ],
  "tree_references": [
    {
      "from_tree": "NSCL-3",
      "to_tree": "NSCL-E",
      "description": "Footnote 'q' on 'Evaluate for perioperative therapy' refers to Perioperative Systemic Therapy (NSCL-E)."
    },
    {
      "from_tree": "NSCL-3",
      "to_tree": "NSCL-B",
      "description": "Footnote 'm' on 'Surgical exploration and resection' and 'thoracic surgeon' refers to Principles of Surgical Therapy (NSCL-B)."
    },
    {
      "from_tree": "NSCL-3",
      "to_tree": "NSCL-4",
      "description": "Directs to guidelines for 'Findings at Surgery'."
    },
    {
      "from_tree": "NSCL-3",
      "to_tree": "NSCL-C",
      "description": "Footnote 'p' on 'SABR' and footnote 'n' on 'adjuvant chemotherapy' refer to Principles of Radiation Therapy (NSCL-C)."
    },
    {
      "from_tree": "NSCL-3",
      "to_tree": "NSCL-17",
      "description": "Directs to 'Surveillance' guidelines."
    },
    {
      "from_tree": "NSCL-3",
      "to_tree": "NSCL-10",
      "description": "Directs to guidelines for medically inoperable N1 patients."
    },
    {
      "from_tree": "NSCL-3",
      "to_tree": "NSCL-8",
      "description": "Directs to guidelines for Stage IIIA/IIIB disease."
    },
    {
      "from_tree": "NSCL-3",
      "to_tree": "NSCL-13",
      "description": "Directs to guidelines for Stage IIIB/IIIC disease."
    }
  ],
  "extraction_confidence": 0.98,
  "image_title": "NCCN Guidelines Version 3.2025 Non-Small Cell Lung Cancer"
}